You're viewing a public preview of Chr. Olesen Synthesis A/S Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Chr. Olesen Synthesis A/S

Active PE Backed
Kanalholmen 8,  Hvidovre,  2650,  Denmark
+45 3679 4500
Sector: Life Science Entity: Private Founded: 2011
2011
Founded
Year established
2
Transactions
Sign up to view
About Chr. Olesen Synthesis A/S
Chr. Olesen Synthesis A/S is a Danish pharmaceutical manufacturing company specializing in the development and production of active pharmaceutical ingredients (APIs) and advanced intermediates, with a particular focus on controlled substances. Its product portfolio includes APIs and intermediates based on opioid and amphetamine chemistry, including buprenorphine for opioid-use-disorder treatment, dexamphetamine and lisdexamfetamine for ADHD treatment, and hydromorphone. The company operates a cGMP-certified manufacturing facility with more than 8,000 square meters of production space and provides contract development and production services for pharmaceutical companies. Its products are supplied to pharmaceutical customers across Europe, North America, and the Middle East. The business has operated at its Hvidovre production site since the 1970s through several ownership changes, while Chr. Olesen Synthesis A/S was established in 2011 after Chr. Olesen Pharmaceuticals acquired the plant. The company is headquartered in Hvidovre, Denmark.
Investors
Current Investors
Samfara LLP ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Chr. Olesen Synthesis A/S M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Chr. Olesen Synthesis A/S do?
Chr. Olesen Synthesis A/S is a Danish pharmaceutical manufacturing company specializing in the development and production of active pharmaceutical ingredients (APIs) and advanced intermediates, with a particular focus on controlled substances. Its product portfolio includes APIs and intermediates ba
Where is Chr. Olesen Synthesis A/S headquartered?
Chr. Olesen Synthesis A/S is headquartered in Hvidovre, Denmark.
When was Chr. Olesen Synthesis A/S founded?
Chr. Olesen Synthesis A/S was founded in 2011.
What sector is Chr. Olesen Synthesis A/S in?
Chr. Olesen Synthesis A/S operates in the Life Science sector.
Who are the investors in Chr. Olesen Synthesis A/S?
Current investors in Chr. Olesen Synthesis A/S include Samfara LLP. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Chr. Olesen Synthesis A/S been involved in?
Chr. Olesen Synthesis A/S has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Chr. Olesen Synthesis A/S profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Chr. Olesen Synthesis A/S's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial